Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-03
2007-04-03
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S044000, C546S045000, C546S046000, C546S039000, C546S074000, C514S279000, C514S289000
Reexamination Certificate
active
10486536
ABSTRACT:
The present disclosure concerns compounds of formula (I) and pharmaceutically acceptable salts, hydrates, solvates, pharmaceutically acceptable derivatives, pro-drugs, tautomers and/or isomers thereof. The disclosure also relates to processes for the preparation of compounds according to formula (I), pharmaceutical or veterinary compositions containing such compounds or methods of treatment and/or prophylaxis of a condition or symptom that is inhibited, reduced or alleviated by opioid receptor activation
REFERENCES:
patent: 3341538 (1967-09-01), Block et al.
patent: 6784186 (2004-08-01), Jackson et al.
patent: WO9938869 (1999-08-01), None
patent: WO 02/18348 (2002-03-01), None
Jackson William Roy
Subasinghe Kamani Rupika
Aulakh Charanjit S.
Klarquist & Sparkman, LLP
Monash University
Neuro Therapeutics Limited
LandOfFree
Derivatives of morphine-like opioid compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of morphine-like opioid compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of morphine-like opioid compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3764763